FDA Brief

Warning letters Biologics

FDA warning letter to

Hemarus LLC

Issued Oct 8, 2024Posted Oct 15, 2024Center for Biologics Evaluation and Research (CBER)

CGMP/Blood & Blood Components/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.